Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
David A Wohl, MD
With
Purpose: This study will be a single arm, prospective cohort study to examine the safety, efficacy, and pharmacokinetic and metabolic characteristics of Raltegravir in African-American men and women. Participants: 40 HIV positive, ARV treatment-naive, African-American women and men (estimated to be 70% men, 30% women) Procedures (methods): Subjects will receive Raltegravir 400 mg BID along with Truvada for 104 weeks.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted